E-LIB Suche - Ergebnisse für: John H. Rex

1

Multi-year analysis of the global preclinical antibacterial..:

Gigante, Valeria ; Alm, Richard A. ; Melchiorri, Daniela...
Antimicrobial Agents and Chemotherapy. , 2024

Link: https://doi.org/10.1128/..

2

Food and Drug Administration Public Workshop Summary—Develo..:

Yasinskaya, Yuliya ; Bala, Shukal ; Waack, Ursula...
Clinical Infectious Diseases. 77 (2023) 3 - p. 380-387 , 2023

Link: https://doi.org/10.1093/..

3

Global Pull Incentives for Better Antibacterials: The UK Le..:

Outterson, Kevin ; Rex, John H.
Applied Health Economics and Health Policy. 21 (2023) 3 - p. 361-364 , 2023

Link: https://doi.org/10.1007/..

4

594. An Open-Label Study in Healthy Volunteers to Determine..:

Cornelissen, Karen ; Newell, Paul A ; Rex, John H...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

5

The Value of the Information That Can Be Generated: Optimiz..:

Dane, Aaron ; Rex, John H ; Newell, Paul.
Open Forum Infectious Diseases. 9 (2022) 7 - p. , 2022

Link: https://doi.org/10.1093/..

6

595. Olorofim (OLO) for treatment of invasive mould infecti..:

Cornelissen, Karen ; Wright, James G ; Cristinacce, Andrew...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

7

754. Olorofim for treatment of invasive fungal infections (..:

Maertens, Johan A ; Thompson, George R ; Spec, Andrej...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

8

870. Olorofim for the treatment of invasive mould infection..:

Maertens, Johan A ; Verweij, Paul E ; Lanuza, Evan F...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

9

Analysis of the Clinical Pipeline of Treatments for Drug-Re..:

Butler, Mark S. ; Gigante, Valeria ; Sati, Hatim...
Antimicrobial Agents and Chemotherapy. 66 (2022) 3 - p. , 2022

Link: https://doi.org/10.1128/..

10

Antibiotic Development Incentives That Reflect Societal Val..:

Boucher, Helen W ; File, Thomas M ; Fowler, Vance G...
Clinical Infectious Diseases. 72 (2021) 9 - p. e420-e421 , 2021

Link: https://doi.org/10.1093/..

11

FDA Public Workshop Summary—Coccidioidomycosis (Valley Feve..:

O'Shaughnessy, Elizabeth ; Yasinskaya, Yuliya ; Dixon, Cheryl...
Clinical Infectious Diseases. 74 (2021) 11 - p. 2061-2066 , 2021

Link: https://doi.org/10.1093/..

12

Antimicrobial Resistance: Is Health Technology Assessment P..:

Colson, Abigail R. ; Morton, Alec ; Årdal, Christine...
Value in Health. 24 (2021) 12 - p. 1828-1834 , 2021

Link: https://doi.org/10.1016/..

13

When to change treatment of acute invasive aspergillosis: a..:

Slavin, Monica A ; Chen, Yee-Chun ; Cordonnier, Catherine...
Journal of Antimicrobial Chemotherapy. 77 (2021) 1 - p. 16-23 , 2021

Link: https://doi.org/10.1093/..

14

Antibacterial R&D at a Crossroads: We've Pushed as Hard as ..:

Rex, John H ; Outterson, Kevin
Clinical Infectious Diseases. 73 (2020) 11 - p. e4451-e4453 , 2020

Link: https://doi.org/10.1093/..

15

Evaluating for-profit public benefit corporations as an add..:

Outterson, Kevin ; Rex, John H.
Translational Research. 220 (2020) - p. 182-190 , 2020

Link: https://doi.org/10.1016/..